32.41 0.00 (0.00%)
After hours: 5:00PM EST
|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||31.79 - 32.60|
|52 Week Range||30.79 - 54.62|
|Beta (3Y Monthly)||-0.05|
|PE Ratio (TTM)||20.01|
|Earnings Date||Feb 6, 2019|
|Forward Dividend & Yield||0.48 (1.44%)|
|1y Target Est||35.33|
# Phibro Animal Health Corp ### NASDAQ NMS:PAHC View full report here! ## Summary * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is extremely low for PAHC with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PAHC. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $1.46 billion over the last one-month into ETFs that hold PAHC are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to email@example.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
TEANECK, N.J., Jan. 02, 2019 -- Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 6, 2019, after.
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll look at Phibro Animal Health Corporation's (NASDAQ:PAHC) P/E ratio and reflect Read More...
It is not a riddle — it’s mycotoxins, which dairy producers must contend with on a regular basis. Fortunately, the more you know about mycotoxins, the easier they are to prevent, recognize and mitigate. Unfortunately, mycotoxins routinely occur in feeds.
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed heavily on the minds of investors. Both the S&P 500 and Russell 2000 sank as a result, with the Russell 2000, […]
Phibro Animal Health Corporation could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Phibro Animal Health Corporation (PAHC) today announced it has acquired the assets of KoVax Ltd., an Israel-based developer and manufacturer of vaccines for the global aquaculture market. The acquisition strengthens Phibro’s position in fish vaccine innovation and expands its portfolio of aquaculture products. Phibro’s first commercial aquaculture vaccine is KoVax’s “KV3” vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms.
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Phibro Animal Health (PAHC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Jack Bendheim became the CEO of Phibro Animal Health Corporation (NASDAQ:PAHC) in 2014. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will Read More...
Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.
The Teaneck, New Jersey-based company said it had net income of 40 cents per share. Earnings, adjusted for non-recurring gains, were 39 cents per share. The maker of animal health products and nutritional ...
TEANECK, N.J., Nov. 05, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
Short interest is extremely low for PAHC with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PAHC. The net inflows of $3.78 billion over the last one-month into ETFs that hold PAHC are not among the highest of the last year and have been slowing.